Improved Assay for Quantifying a Redox Form of Angiotensinogen as a Biomarker for Pre-Eclampsia: A Case-Control Study

• Soheila Rahgozar,

  Affiliation Department of Biology, Faculty of Science, University of Isfahan, Isfahan, Iran

  ⨯
• Tayebeh Amirian,

  Affiliation Department of Biology, Faculty of Science, University of Isfahan, Isfahan, Iran

  ⨯
• Miao Qi,

  Affiliation Department of Infectious Diseases, Immunology and Sexual Health and Department of Medicine, St George Hospital, University of New South Wales, Sydney, Australia

  ⨯
• Zahra Shahshahan,

  Affiliation Department of Obstetrics and Gynaecology, Shahid Beheshti Hospital, Isfahan University of Medical Sciences, Isfahan, Iran

  ⨯
• Mansureh Entezar-E-Ghaem,

  Affiliation Department of Biology, Faculty of Science, University of Isfahan, Isfahan, Iran

  ⨯
• Hatav Ghasemi Tehrani,

  Affiliation Department of Obstetrics and Gynaecology, Shahid Beheshti Hospital, Isfahan University of Medical Sciences, Isfahan, Iran

  ⨯
• Mehran Miroliaei,

  Affiliation Department of Biology, Faculty of Science, University of Isfahan, Isfahan, Iran

  ⨯
• Steven A. Krilis ,

  Contributed equally to this work with: Steven A. Krilis, Bill Giannakopoulos

  Affiliation Department of Infectious Diseases, Immunology and Sexual Health and Department of Medicine, St George Hospital, University of New South Wales, Sydney, Australia

  ⨯
• Bill Giannakopoulos

  Contributed equally to this work with: Steven A. Krilis, Bill Giannakopoulos

  * E-mail: bill.giannakopoulos@unsw.edu.au

  Affiliation Department of Infectious Diseases, Immunology and Sexual Health and Department of Medicine, St George Hospital, University of New South Wales, Sydney, Australia

  ⨯